Liguori et al. found that in AD, higher levels of cerebrospinal fluid AD biomarkers, including total tau and phosphorylated-tau, corresponded to lower concentrations of lactate, suggesting links between the pathological processes present in AD and impairment of neuronal energy metabolism 64. This evidence concerns the gene MAPT and Alzheimer disease.